LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

LLY

1,159.67

+1.84%↑

JNJ

238

-0.36%↓

ABBV

224.7

-0.26%↓

UNH

405.21

-0.45%↓

MRK

120.56

+1.31%↑

Search

Ovid therapeutics Inc

Gesloten

SectorGezondheidszorg

2.2 -3.51

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.16

Max

2.2800000000000002

Belangrijke statistieken

By Trading Economics

Inkomsten

-27M

-17M

EPS

-0.125

Winstmarge

-2,366.017

Werknemers

23

EBITDA

-5.5M

-18M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+133.77% upside

Dividenden

By Acuity

Volgende Winsten

12 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-42M

440M

Vorige openingsprijs

5.71

Vorige sluitingsprijs

2.2

Nieuwssentiment

By Acuity

50%

50%

154 / 344 Rangschikking in Healthcare

Ovid therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 jun 2026, 23:56 UTC

News

Monster Beverage shares higher in after-market trading following Bernstein's initiation of coverage with a Market Perform rating. The stock has gained over four consecutive sessions.

11 jun 2026, 23:52 UTC

Macro Event
News
Correlated Moves

The Australian Dollar has gained against the Singapore Dollar, supported by a slight decline in consumer inflation expectations and recent geopolitical developments.

11 jun 2026, 23:51 UTC

News

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, reflecting concerns over inflation following a rise in the producer price index.

11 jun 2026, 23:51 UTC

Correlated Moves
ETF Constituents
News
Social Media

SPDR S&P 500 ETF Trust rises in after-hours trading amid improved market sentiment and reduced geopolitical tensions in Iran, supported by strong performances from top holdings.

11 jun 2026, 23:51 UTC

Correlated Moves
ETF Constituents
News
Social Media

Invesco QQQ Trust Series I rises after hours, supported by a Nasdaq 100 rally driven by technology stocks and easing inflation concerns.

11 jun 2026, 23:51 UTC

News

The United States Oil Fund LP is higher in after-market trading amid reports of explosions in Iran raising concerns over oil supply stability.

11 jun 2026, 23:41 UTC

Social Media
News
Event

Adobe Inc. shares fell in after-market trading despite record revenue of $6.62 billion, as investor concerns grew over CFO Dan Durn's upcoming departure.

11 jun 2026, 23:41 UTC

ETF Constituents
Correlated Moves
Macro News
News

Vanguard Information Technology ETF rises after President Trump's decision to call off attacks against Iran, boosting investor confidence and contributing to gains in major indices.

11 jun 2026, 23:41 UTC

Social Media
News

Western Digital Corp initiated exchange agreements with investors for over 1 million shares of SanDisk, contributing to the stock's higher after-market hours movement.

11 jun 2026, 23:36 UTC

News
Correlated Moves

Ethereum is trading higher as market optimism rises amid U.S.-Iran tensions and the European Central Bank's interest rate hike. Earlier, it pulled back from a peak.

11 jun 2026, 23:31 UTC

News

NVIDIA shares are higher in after-market trading following an upgrade to 'AA' by S&P Global and the announcement of its 2026 Annual Meeting.

11 jun 2026, 23:26 UTC

ETF Constituents
Correlated Moves
News

Vanguard Growth ETF rises in after-market trading, buoyed by gains from Microsoft, NVIDIA, and Alphabet, despite remaining below its 20-day moving average.

11 jun 2026, 23:16 UTC

ETF Constituents
Social Media
News
Correlated Moves

The iShares Russell 2000 ETF rose in after-market hours, supported by the Russell 2000 index's significant gain and contributions from PR and SATS.

11 jun 2026, 23:11 UTC

News
Correlated Moves

CME Group plans to expand 24/7 gold trading, pending regulatory review. SPDR Gold Shares are rising in after-market hours amid geopolitical tensions.

11 jun 2026, 23:11 UTC

News

USD/PLN trades lower as natural gas storage exceeds forecasts and initial jobless claims rise unexpectedly. Volatility persists during Thursday's session.

11 jun 2026, 23:11 UTC

News
Correlated Moves

The USD/CZK is trading lower, reflecting a decline since Wednesday's close amid rising initial jobless claims and producer prices exceeding forecasts.

11 jun 2026, 23:06 UTC

Correlated Moves
News

Vanguard Total Bond Market ETF trades higher in after-market hours as producer prices exceed expectations, prompting bargain hunting despite potential interest rate hike concerns.

11 jun 2026, 23:06 UTC

News

Amgen engages Duke Clinical Research Institute to reassess Tavneos data amid FDA concerns, with shares trading higher in after-market hours.

11 jun 2026, 23:03 UTC

Social Media
Correlated Moves
News

iShares Silver Trust trades higher after geopolitical tensions in Iran raise interest in safe-haven assets, supported by gold's recent gains.

11 jun 2026, 23:03 UTC

ETF Constituents
News

The Vanguard Small-Cap ETF is higher in after-market trading, reflecting a broader upward trend in the Russell 2000 Index amid ongoing inflationary concerns.

11 jun 2026, 23:02 UTC

News

The USD/THB is lower as U.S. economic data raises inflation concerns, impacting sentiment and Federal Reserve policy expectations during Thursday's trading session.

11 jun 2026, 23:02 UTC

News

Gilead Sciences reported positive results from two Phase 3 trials for an HIV treatment. Shares are higher in after-market hours following a session pullback.

11 jun 2026, 23:02 UTC

News

The USD/HUF is trading lower, reflecting a drop since Wednesday. Rising jobless claims and surging producer prices raise concerns about labor market strength and inflation.

11 jun 2026, 23:02 UTC

Correlated Moves
News

The USD/SEK is declining, breaking a trend of higher daily closes, amid rising initial jobless claims that may impact Federal Reserve policy.

11 jun 2026, 22:51 UTC

Correlated Moves
News

USD/SGD declines amid natural gas storage data surpassing forecasts. The pair has experienced unusual volatility, peaking briefly before steady declines into the afternoon.

11 jun 2026, 22:51 UTC

Correlated Moves
News

The CHF/HKD is higher during Thursday's session, supported by the European Central Bank's recent interest rate hike amid inflation pressures.

11 jun 2026, 20:07 UTC

News
Correlated Moves

The European Central Bank raised interest rates by 25 basis points, supporting modest gains in GBP/HKD amid inflation pressures from the Middle East conflict.

11 jun 2026, 20:07 UTC

News
Correlated Moves

Natural gas storage data showed 108 billion cubic feet, surpassing forecasts. USD/NOK is trading higher, remaining above its 20-day moving average.

11 jun 2026, 20:07 UTC

News
Correlated Moves

The USD/DKK is lower in Thursday's session, reflecting a decline in the US Dollar Index amid rising initial jobless claims data.

11 jun 2026, 20:06 UTC

News
Correlated Moves

Intel Corp's stock is rising following a double upgrade from Bank of America, which raised its price target to $135 from $96.

Peer Vergelijking

Prijswijziging

Ovid therapeutics Inc Prognose

Koersdoel

By TipRanks

133.77% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 5.33 USD  133.77%

Hoogste 7 USD

Laagste 4 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Ovid therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

8 ratings

8

Buy

0

Hold

0

Sell

Sentiment

By Acuity

154 / 344 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Ovid therapeutics Inc

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing soticlestat, a novel cholesterol 24 hydroxylase inhibitor, which is in Phase 3 clinical trials for the potential treatment of patients with resistant epilepsies; OV329, a GABA aminotransferase inhibitor which is in Phase 1 clinical trials for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It also develops OV815, that focuses on the mutations associated with KIF1A-associated neurological disorder (KAND); OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial; OV825, has advanced to potential candidate lead identification for the rare neurodevelopmental condition HNRNPH2 (Bain Syndrome); and OV882, a short hairpin RNA gene therapy for the treatment of Angelman syndrome. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
help-icon Live chat